SIGA mpox therapy no longer recommended in EU
Source: SeekingAlpha
2026-03-27 09:21:20 ET
More on SIGA Technologies
- SIGA Technologies, Inc. (SIGA) Q4 2025 Earnings Call Transcript
- SIGA outlines continued TPOXX global expansion and expects EMA smallpox decision in March 2026
- Historical earnings data for SIGA Technologies
- Financial information for SIGA Technologies
Read the full article on Seeking Alpha
For further details see:
SIGA mpox therapy no longer recommended in EU
SIGA Technologies Inc.
NASDAQ: SIGA
SIGA Trading
6.69% G/L:
$5.34 Last:
671,443 Volume:
$5.33 Open:
